• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚萨拉迪迪村的志愿卫生工作者使用磷酸氯喹治疗疟疾的情况。

Consumption of chloroquine phosphate provided for treatment of malaria by volunteer village health workers in Saradidi, Kenya.

作者信息

Spencer H C, Kaseje D C, Roberts J M, Huong A Y

机构信息

Kenya Medical Research Institute, Clinical Research Centre, Nairobi.

出版信息

Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:116-23. doi: 10.1080/00034983.1987.11812197.

DOI:10.1080/00034983.1987.11812197
PMID:3689032
Abstract

A community-based malaria control programme in Saradidi, Kenya provided chloroquine treatment for malaria in each village beginning in May 1982. Malaria was holoendemic in Saradidi. Treatment was provided by volunteer community health workers chosen and supported by the village. Consumption of the drug and characteristics of persons treated were recorded. Between 1 September 1982 to 31 August 1983, 40,649 treatments with chloroquine were given to village residents. The treatment rate per person in the mid-year population was 1.24. However, at least 41.8% of the mid-year population of 32,650 did not receive a single treatment. Multiple treatments were given to 50.5% of persons treated at least once and 13.4% of 13,879 persons treated at least once received five or more treatments during the year. Consumption patterns were not random: they were higher in females, in persons above 30 years of age and in the area with greater community organization and community participation. There is need to ascertain the reasons why so large a proportion of the population never received a single treatment in this highly malarious area and why adults who should not have had a high frequency of clinical malaria were treated so often. Nonetheless, the results demonstrate that volunteer community health workers can effectively provide treatment for malaria.

摘要

肯尼亚萨拉迪迪实施了一项基于社区的疟疾控制项目,自1982年5月起在每个村庄提供氯喹治疗疟疾。疟疾在萨拉迪迪呈高度地方性流行。治疗由村庄挑选并支持的社区志愿卫生工作者提供。记录了药物的使用情况和接受治疗者的特征。在1982年9月1日至1983年8月31日期间,共对村庄居民进行了40,649次氯喹治疗。年中人口的人均治疗率为1.24。然而,年中32,650人的人口中至少41.8%未接受过一次治疗。至少接受过一次治疗的人中,50.5%接受了多次治疗,在至少接受过一次治疗的13,879人中,13.4%在该年接受了五次或更多次治疗。用药模式并非随机:女性、30岁以上人群以及社区组织和社区参与度较高地区的用药率更高。有必要查明在这个疟疾高发地区为何有如此大比例的人口从未接受过一次治疗,以及为何本不应频繁患临床疟疾的成年人却接受了如此频繁的治疗。尽管如此,结果表明社区志愿卫生工作者能够有效地提供疟疾治疗。

相似文献

1
Consumption of chloroquine phosphate provided for treatment of malaria by volunteer village health workers in Saradidi, Kenya.肯尼亚萨拉迪迪村的志愿卫生工作者使用磷酸氯喹治疗疟疾的情况。
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:116-23. doi: 10.1080/00034983.1987.11812197.
2
Usage of community-based chloroquine treatment for malaria in Saradidi, Kenya.肯尼亚萨拉迪迪基于社区的氯喹治疗疟疾的应用情况。
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:111-5. doi: 10.1080/00034983.1987.11812196.
3
Changes in sources of treatment occurring after inception of a community-based malaria control programme in Saradidi, Kenya.在肯尼亚萨拉迪迪开展基于社区的疟疾控制项目后,治疗来源发生的变化。
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:105-10. doi: 10.1080/00034983.1987.11812195.
4
Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya.
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:124-7. doi: 10.1080/00034983.1987.11812198.
5
A community-based programme to provide prompt and adequate treatment of presumptive malaria in children.一项基于社区的计划,旨在为儿童的推定疟疾提供及时且充分的治疗。
Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):512-7. doi: 10.1016/s0035-9203(97)90006-7.
6
Characteristics and functions of community health workers in Saradidi, Kenya.肯尼亚萨拉迪迪社区卫生工作者的特征与职能
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:56-66. doi: 10.1080/00034983.1987.11812189.
7
Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies.肯尼亚萨拉迪迪基于社区的疟疾控制:项目描述及其对寄生虫血症发生率和抗疟抗体的影响
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:13-23. doi: 10.1080/00034983.1987.11812185.
8
Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. II. Effect on parasitaemia and haemoglobin levels.肯尼亚萨拉迪迪社区卫生工作者为孕妇提供的疟疾化学预防。二、对寄生虫血症和血红蛋白水平的影响。
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:83-9. doi: 10.1080/00034983.1987.11812192.
9
Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance.肯尼亚萨拉迪迪社区卫生工作者为孕妇提供的疟疾化学预防。一、不接受的原因。
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:77-82. doi: 10.1080/00034983.1987.11812191.
10
Changing response to chloroquine of Plasmodium falciparum in Saradidi, Kenya, from 1981 to 1984.1981年至1984年肯尼亚萨拉迪迪恶性疟原虫对氯喹反应的变化
Ann Trop Med Parasitol. 1987 Apr;81 Suppl 1:98-104. doi: 10.1080/00034983.1987.11812194.

引用本文的文献

1
The changing limits and incidence of malaria in Africa: 1939-2009.非洲疟疾的变化范围和发病率:1939-2009 年。
Adv Parasitol. 2012;78:169-262. doi: 10.1016/B978-0-12-394303-3.00010-4.
2
Knowledge, attitudes and practices relevant to malaria control in remote island populations of manus, papua new Guinea.与巴布亚新几内亚马努斯偏远岛屿人群疟疾控制相关的知识、态度和行为
Trop Med Health. 2011 Dec;39(4):109-17. doi: 10.2149/tmh.2011-14. Epub 2011 Dec 1.
3
Impact of community-based presumptive chloroquine treatment of fever cases on malaria morbidity and mortality in a tribal area in Orissa State, India.
印度奥里萨邦一个部落地区基于社区的发热病例推定氯喹治疗对疟疾发病率和死亡率的影响。
Malar J. 2008 May 5;7:75. doi: 10.1186/1475-2875-7-75.
4
Antimalarial drug quality in Africa.非洲抗疟药物的质量
J Clin Pharm Ther. 2007 Oct;32(5):429-40. doi: 10.1111/j.1365-2710.2007.00847.x.
5
Reconciling national treatment policies and drug regulation in Kenya.协调肯尼亚的国民待遇政策与药品监管
Health Policy Plan. 2007 Mar;22(2):111-2. doi: 10.1093/heapol/czl038. Epub 2007 Jan 15.
6
Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.撒哈拉以南非洲地区恶性疟原虫疟疾的治疗:从分子到政策
Clin Microbiol Rev. 2004 Jul;17(3):612-37, table of contents. doi: 10.1128/CMR.17.3.612-637.2004.